InsiderTrades

Form 4 for APVO Aptevo Therapeutics Inc.

Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-02 · accession 0000950170-24-025878 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-03-05 2024-03-02+ APVO White Marvin L Pres, CEO, Dir M - OptEx — +22.5K 67.4K +50% —
DM 2024-03-05 2024-03-02+ APVO White Marvin L Pres, CEO, Dir M - OptEx $0.00 -22.5K 25.8K -47% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-03-02 M A 12,917 — 57,846 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
2 Common Common Stock 2024-03-03 M A 9,584 — 67,430 D — — (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
3 Derivative Restricted Stock Unit 2024-03-03 M D 9,584 $0.00 9,584 D — · — to — 9,584 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F3) On June 7, 2022, the reporting person was granted 28,750 RSUs, vesting in three approximately equal annual installments beginning on March 3, 2023.
4 Derivative Restricted Stock Unit 2024-03-02 M D 12,917 $0.00 25,833 D — · — to — 12,917 Common Stock (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On March 3, 2023, the reporting person was granted 38,750 RSUs, vesting in three approximately equal annual installments beginning on March 2, 2024.